AAAAAA
Results: 26-37/37
Authors:
GOCH J
BIRGEGARD G
DANIELSON BG
WIKSTROM B
Citation: J. Goch et al., IRON-ABSORPTION IN PATIENTS WITH CHRONIC UREMIA ON MAINTENANCE HEMODIALYSIS AND IN HEALTHY-VOLUNTEERS MEASURED WITH A SIMPLE ORAL IRON LOADTEST, Nephron, 73(3), 1996, pp. 403-406
Authors:
SJODEN GOJ
MOVIN T
SPERBER A
GUNTNER P
WIKSTROM B
Citation: Goj. Sjoden et al., CUFF TEAR ARTHROPATHY WITH HEMARTHROSIS - A REPORT ON 3 ELDERLY PATIENTS, Acta orthopaedica Scandinavica, 67(6), 1996, pp. 571-574
Authors:
GOCH J
BIRGEGARD G
DANIELSON BG
WIKSTROM B
Citation: J. Goch et al., TREATMENT OF ERYTHROPOIETIN-RESISTANT ANEMIA WITH DESFERRIOXAMINE IN PATIENTS ON HEMOFILTRATION, European journal of haematology, 55(2), 1995, pp. 73-77
Authors:
ALARABI A
BACKMAN U
WIKSTROM B
SJOBERG O
TUFVESON G
Citation: A. Alarabi et al., PRETRANSPLANTATION PLASMAPHERESIS IN HLA-SENSITIZED PATIENTS - 5 YEARS EXPERIENCE, Transplantation proceedings, 27(6), 1995, pp. 3448-3448
Authors:
FELLSTROM B
BACKMAN U
DANIELSON B
WIKSTROM B
Citation: B. Fellstrom et al., TREATMENT OF RENAL CALCIUM STONE DISEASE WITH THE SYNTHETIC GLYCOSAMINOGLYCAN PENTOSAN POLYSULFATE, World journal of urology, 12(1), 1994, pp. 52-54
Authors:
LINDE T
RONQUIST G
SANDHAGEN B
WIKSTROM B
FRITHZ G
PETTERSSON L
DANIELSON BG
Citation: T. Linde et al., TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN RESULTS IN DECREASED RED-CELL UPTAKE OF CA-45, Nephron, 68(4), 1994, pp. 419-426
Authors:
LINDE T
SANDHAGEN B
BRATTEBY LE
DEVERDIER CH
DANIELSON BG
WIKSTROM B
Citation: T. Linde et al., REDUCED OXYGEN-AFFINITY CONTRIBUTES TO IMPROVED OXYGEN RELEASING CAPACITY DURING ERYTHROPOIETIN TREATMENT OF RENAL ANEMIA, Nephrology, dialysis, transplantation, 8(6), 1993, pp. 524-529
BLOOD-VISCOSITY AND PERIPHERAL VASCULAR-RESISTANCE IN PATIENTS WITH UNTREATED ESSENTIAL-HYPERTENSION
Authors:
LINDE T
SANDHAGEN B
HAGG A
MORLIN C
WIKSTROM B
DANIELSON BG
Citation: T. Linde et al., BLOOD-VISCOSITY AND PERIPHERAL VASCULAR-RESISTANCE IN PATIENTS WITH UNTREATED ESSENTIAL-HYPERTENSION, Journal of hypertension, 11(7), 1993, pp. 731-736
Authors:
ALARABI AA
NILSSON B
NILSSON U
WIKSTROM B
DANIELSON BG
Citation: Aa. Alarabi et al., COMPLEMENT ACTIVATION DURING TRYPTOPHAN IMMUNOADSORPTION TREATMENT, Artificial organs, 17(9), 1993, pp. 782-786
Authors:
ALARABI AA
WIKSTROM B
BACKMAN U
DANIELSON BG
TUFVESSON G
SJOBERG O
Citation: Aa. Alarabi et al., PRETRANSPLANTATION IMMUNOADSORPTION THERAPY IN PATIENTS IMMUNIZED WITH HUMAN LYMPHOCYTE ANTIGEN - EFFECT OF TREATMENT AND 3 YEARS CLINICAL FOLLOW-UP OF GRAFTS, Artificial organs, 17(8), 1993, pp. 702-707
Authors:
GARDLUND B
SJOLIN J
NILSSON A
ROLL M
WICKERTS CJ
WIKSTROM B
WRETLIND B
Citation: B. Gardlund et al., PLASMAPHERESIS IN THE TREATMENT OF PRIMARY SEPTIC SHOCK IN HUMANS, Scandinavian journal of infectious diseases, 25(6), 1993, pp. 757-761
Authors:
ALARABI AA
DANIELSON BG
WIKSTROM B
Citation: Aa. Alarabi et al., CONTINUOUS ARTERIOVENOUS HEMODIALYSIS - OUTCOME IN INTENSIVE-CARE ACUTE-RENAL-FAILURE PATIENTS, Nephron, 64(1), 1993, pp. 58-62